Delivery Order SPE2DB20D1110-SPE2DB25FK27W

This federal contract award, with identification number SPE2DX15D3005|SPE2DX24F3PGF, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $27,360.83 and a completion date of February 5, 2024. The award is not designated as a set-aside contract and is instead awarded through full and...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The delivery order has a ceiling value of $6,121.76 and is a firm fixed-price contract. It does not have a set-aside designation, indicating open competition. The ultimate completion date for this delivery order is May 19, 2025. AmerisourceBergen Drug Corp is a prime contractor that holds a larger $999,999,999.00...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,895.37 firm fixed-price delivery order covers the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a performance period ending on December 12, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a total ceiling value of $4,562.81. The contract has an ultimate completion date of May 19, 2025. This order is not set aside and is awarded as part of a larger Indefinite Delivery Contract (IDC) worth...

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,982.14, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, with a ceiling value of $7,956.12 and an ultimate completion date of June 24, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $2,873.01 and a performance period ending on May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant Indefinite Delivery Contract (IDC) with...

This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMCMM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,878.49. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 21, 2024. The contract is not...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 30-count packages of the drug GEMTESA 75 MG TABLET. The contract has a ceiling value of $2,118.59 and a completion date of July 2, 2025. It is not set aside for any special designation. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $5,332.47. The contract has a firm fixed price pricing type and an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical and medical supply...